Rapidly progressive dementia due to leukocytoclastic vasculitis of the central nervous system

Carolina Pires1, Henda Foreid, Cândida Barroso

  • 1Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal. mcarolinapires@gmail.com

BMJ Case Reports
|June 9, 2012
PubMed

Insights

A 70-year-old man experienced severe cognitive decline due to leukocytoclastic vasculitis, a rare form of primary central nervous system vasculitis. Treatment with steroids led to improvement, highlighting this condition

Area of Science:

  • Neurology
  • Pathology
  • Immunology

Background:

  • Primary angiitis of the central nervous system (PACNS) is a rare condition affecting blood vessels in the brain and spinal cord.
  • PACNS can manifest with diverse neurological symptoms and histopathological findings.
  • Understanding the spectrum of PACNS is crucial for accurate diagnosis and effective treatment.

Observation:

  • A 70-year-old male presented with a 2-week history of rapidly worsening cognitive impairment.
  • Brain MRI revealed extensive white matter abnormalities in the periventricular and subcortical regions, extending to the cortex and basal ganglia.
  • Cerebral angiography did not show any abnormalities.

Findings:

  • Stereotactic brain biopsy confirmed leukocytoclastic vasculitis, characterized by inflammation of small blood vessel walls.
  • Leukocytoclastic vasculitis was identified as the underlying cause of the patient's neurological symptoms.
  • The patient showed significant clinical improvement following treatment with corticosteroids.

Implications:

  • This case expands the known histopathological spectrum of primary angiitis of the central nervous system.
  • Leukocytoclastic vasculitis should be considered in the differential diagnosis of unexplained cognitive decline and white matter lesions.
  • Prompt diagnosis and immunosuppressive therapy, such as steroids, can lead to favorable outcomes in CNS vasculitis.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...